160 Health International Ltd.
2656.HK
Hong Kong Stock Exchange12.81
HKD
-0.35
- -
160 Health International Ltd.
2656.HK
(Hong Kong Stock Exchange)
Recent
price
12.81
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- 160 Health International Limited engages in the wholesale and retail of pharmaceutical and healthcare products, complemented by digital healthcare solutions and online wellness services. The group’s core activities span product distribution, consumer health and medical supplies, and a digital platform ecosystem that supports online marketing, digital hospital solutions, and telehealth-related services for business customers, medical institutions, professionals, individual users, and third-party merchants. The company operates across China, leveraging its online channels and partner networks to deliver a broad suite of pharmaceutical products, medical devices, health and wellness items, and digital health services. Founded in 2005, the company is headquartered in Shenzhen, People’s Republic of China. Its geographic footprint centers on China, with a focus on domestic pharmaceutical trading, regional distribution, and online healthcare solutions that connect pharmaceutical suppliers, healthcare providers, and consumers. The business is organized around two primary segments: (1) physical commerce of pharmaceutical and healthcare products and (2) digital healthcare and wellness solutions delivered through the online platform, which includes online marketing solutions, digital hospital services, and online healthcare services. The group’s subsidiaries and related entities support these operations, enabling integrated supply, distribution, and digital services across its platform participants. Latest major changes include strategic expansion of the digital healthcare platform through a marquee collaboration model branded as “160AI Hospital,” which integrates operational partnerships with public hospitals to scale digital health services. In 2025 the company reports significant growth in hospital collaborations, with a markedly higher number of participating public hospitals year over year, and continued penetration of its digital healthcare and wellness solutions across facilities and patient care pathways. The group emphasizes ongoing partnerships, platform scaling, and service expansion as core elements of its strategic evolution, alongside continued optimization of its product distribution network and digital service offerings. Industry and business segments: healthcare services and pharmaceutical distribution; digital health and wellness solutions; online marketplace and platform services. Target markets and customer types: business customers (pharmaceutical traders and distributors), medical and healthcare institutions, medical professionals, individual users, and third-party merchants. Geographic operations: primarily China, with corporate presence focused in Shenzhen as headquarters. Founding year: 2005. Headquarters: Shenzhen, China. Subsidiaries and parent relationships: organized as a group with multiple subsidiaries delivering pharmaceutical distribution, online healthcare services, and digital health solutions.